Your browser doesn't support javascript.
loading
Histone chaperone CHAF1A impacts the outcome of fluoropyrimidines-based adjuvant therapy in gastric cancer by regulating the expression of thymidylate synthetase.
Wang, Deqiang; Li, Xiaoqin; Shen, Bo; Chen, Xiaofeng; Shu, Yongqian.
Afiliação
  • Wang D; Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road, Nanjing 210029, China; Department of Medical Oncology, Affiliated Hospital of Jiangsu University, Jiefang Road, Zhenjiang 212001, China.
  • Li X; Department of Medical Oncology, Affiliated Hospital of Jiangsu University, Jiefang Road, Zhenjiang 212001, China.
  • Shen B; Department of Medical Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Baiziting Road, Nanjing 210009, China.
  • Chen X; Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road, Nanjing 210029, China.
  • Shu Y; Department of Medical Oncology, The First Affiliated Hospital of Nanjing Medical University, Guangzhou Road, Nanjing 210029, China. Electronic address: yongqian_shu@sina.com.
Gene ; 716: 144034, 2019 Oct 20.
Article em En | MEDLINE | ID: mdl-31377317

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias Gástricas / Timidilato Sintase / Chaperonas de Histonas / Antineoplásicos Tipo de estudo: Prognostic_studies Idioma: En Revista: Gene Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias Gástricas / Timidilato Sintase / Chaperonas de Histonas / Antineoplásicos Tipo de estudo: Prognostic_studies Idioma: En Revista: Gene Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China